Stem Cell Provider // Beike Biotechnology Co., Ltd.

Beike Biotechnology is the world’s largest stem cell provider and a leading cell therapy company. Using Beike Biotechnology’s cutting edge adult stem cell treatment protocols, we are able to treat a wide range of medical conditions, we are helping patients find hope.
Beike Biotechnology has established more than 20 adult stem cell processing laboratories, in accordance with GMP standards, and has been awarded ISO9001 and ISO17025 certificates. Jiangsu Beike’s inspection center was accredited by the China National Accreditation Service for Conformity Assessment (CNAS) in 2011, and it is the first adult stem cell processing laboratory accredited by CNAS. Beike Biotechnology also successfully completed on-site evaluation for AABB (American Association of Blood Bank) accreditation in September 2011. With this level of safety and efficacy, patient’s can rest assured that they are receiving the highest quality umbilical-cord derived adult stem cells.

History of Beike Biotechnology

Beike is a Chinese biotechnology company with main offices in Shenzhen (near Hong Kong) and Taizhou. Beike’s stem cell research and clinical applications were developed starting in the 1990s. Over 60 PhDs from leading Chinese universities contributed to advancing Beike’s treatment technologies. Many of Beike’s scientists also have experience at leading Western universities, including Stanford, the University of Minnesota, and UCLA.


The first patient (who happened to be diagnosed with ALS) to be treated with Beike processed cells was in 2001. Over 200 patients participated in studies and were treated between 2001 to 2005 in order to determine treatment efficacy for a small number of end-stage and otherwise incurable diseases. Beike was incorporated in July 2005 and has since provided partner hospitals with stem cells for the treatment of over 16,000 patients. Beike currently maintains 25 laboratories for both research and cell processing for clinical use and has received over US$6 million in government grants. We even recently had the honor of welcoming Chinese Premier Wen Jiabao for a tour of our Shenzhen facilities in August of 2010.


Unlike many stem cell treatment clinics, Beike itself is a dedicated research organization. Our vigor for helping patients extends far beyond simply using stem cells for clinical treatments based on other’s research. Beike extends its actual scientific research into cell technologies, and Beike has been one of the world leaders in this important research. This allows Beike’s treatment protocols and stem cell processing to not only be guided by 3rd party research, but also their own. Beike has almost 50 published peer-reviewed research papers in scientific journals around the world (such as Nature) and has spent tens of millions over the past decade on scientific laboratories and cell research.


Since 2005, Beike has provided partner hospitals with stem cells for the treatment of over 16,000 patients. Beike currently provides more than 30 hospitals with umbilical cord, cord blood, and bone marrow-derived stem cells for the treatment of neurological and vascular diseases. Being the provider, Beike is able to maintain full oversight over cell manufacturing, from the testing of blood products, to cell processing at our laboratories, to delivery of the cells for clinical use. This ensures cell safety and quality. Beike also works closely with our partner hospitals in the evolving of treatment protocols and patient care. Each partner hospital maintains Beike staff to assist patients both with the treatment and with general needs during the hospital stay.

History of Beike Biotechnology

Beike is a Chinese biotechnology company with main offices in Shenzhen (near Hong Kong) and Taizhou. Beike’s stem cell research and clinical applications were developed starting in the 1990s. Over 60 PhDs from leading Chinese universities contributed to advancing Beike’s treatment technologies. Many of Beike’s scientists also have experience at leading Western universities, including Stanford, the University of Minnesota, and UCLA.


The first patient (who happened to be diagnosed with ALS) to be treated with Beike processed cells was in 2001. Over 200 patients participated in studies and were treated between 2001 to 2005 in order to determine treatment efficacy for a small number of end-stage and otherwise incurable diseases. Beike was incorporated in July 2005 and has since provided partner hospitals with stem cells for the treatment of over 16,000 patients. Beike currently maintains 25 laboratories for both research and cell processing for clinical use and has received over US$6 million in government grants. We even recently had the honor of welcoming Chinese Premier Wen Jiabao for a tour of our Shenzhen facilities in August of 2010.


Unlike many stem cell treatment clinics, Beike itself is a dedicated research organization. Our vigor for helping patients extends far beyond simply using stem cells for clinical treatments based on other’s research. Beike extends its actual scientific research into cell technologies, and Beike has been one of the world leaders in this important research. This allows Beike’s treatment protocols and stem cell processing to not only be guided by 3rd party research, but also their own. Beike has almost 50 published peer-reviewed research papers in scientific journals around the world (such as Nature) and has spent tens of millions over the past decade on scientific laboratories and cell research.


Since 2005, Beike has provided partner hospitals with stem cells for the treatment of over 16,000 patients. Beike currently provides more than 30 hospitals with umbilical cord, cord blood, and bone marrow-derived stem cells for the treatment of neurological and vascular diseases. Being the provider, Beike is able to maintain full oversight over cell manufacturing, from the testing of blood products, to cell processing at our laboratories, to delivery of the cells for clinical use. This ensures cell safety and quality. Beike also works closely with our partner hospitals in the evolving of treatment protocols and patient care. Each partner hospital maintains Beike staff to assist patients both with the treatment and with general needs during the hospital stay.


Treatment Center // Better Being Hospital

Better Being Hospital (BBH) and their medical team in Bangkok, Thailand helps to provide the world’s most extensive stem cell treatment available for our patients. This partnership brings stem cell therapy to another level as BBH is the first accredited center in Asia for Functional Medicine, providing customized supportive therapies for each patient’s unique condition including: Physiotherapy, Aquatherapy, Occupational Therapy, Hyperbaric Oxygen Therapy, Acupuncture, Massage and Nutrition Therapy.
The hospital is based on the principles of Functional Medicine which guides the treatment of each and every chronic illness patient. It is designed as an Integrative Center, where many different treatment modalities can be provided under one roof, aiming at therapeutic lifestyle changes to heal the causes of chronic illness alongside advanced stem cell therapy.

Learn more>>


Cancer and Oncology Treatments // Verita Life

Verita Life is a unique cancer treatment center that compliments conventional cancer treatments to increase your chances of remission. No matter what stage or what kind of cancer you have a plan is designed specifically to get the best outcomes for you efficiently and with as little pain and discomfort to you as possible.Our approach is to use integrative treatments to detoxify your body, enhance your immunity and eliminate cancer cells within the body. We then work together to increase your body’s defenses to help protect you against cancer in the future.
All of our treatment options are research-based and founded in evidence of treatment efficacy. Our medical team is comprised of top international doctors and medical advisers trained in the field of Oncology.

Learn more about Verita’s innovative cancer therapy>>